Alaunos Therapeutics Inc. (TCRT)
NASDAQ: TCRT
· Real-Time Price · USD
2.27
-0.13 (-5.42%)
At close: Aug 15, 2025, 3:59 PM
2.20
-2.87%
After-hours: Aug 15, 2025, 07:31 PM EDT
Alaunos Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -1.07M | -742K | 41.47M | -1.13M | -1.68M | -7.84M | -8.48M | -8.77M | -10.05M | -9.16M | -8.85M | -9.93M | -9.79M | -11.79M | -22.73M | -22.67M | -21.55M |
Depreciation & Amortization | n/a | -1K | -1.35M | 1K | 2K | 241K | 679K | 699K | 696K | 694K | 691K | 685K | 689K | 705K | 673K | 679K | 540K |
Stock-Based Compensation | 68K | 81K | -7.31M | 102K | 172K | 250K | 726K | 914K | 910K | 877K | 808K | 990K | 853K | 917K | 2.37M | 5.29M | 2.2M |
Other Working Capital | n/a | 16K | -7.21M | -421K | -390K | -2.04M | -519K | -1.51M | -1.42M | 638K | -642K | -3.18M | 1.04M | -9.26M | 9.48M | -2.12M | 850K |
Other Non-Cash Items | n/a | 217K | -947K | 1K | 195K | 4.1M | 385K | 1.46M | 585K | 465K | 339K | 2.27M | 198K | 235K | 148K | 11.9M | 963K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -1.41M | 1.01M | 10K | n/a | n/a | n/a | n/a | n/a | 740K | n/a | n/a | n/a |
Change in Working Capital | n/a | 70K | -5.21M | -656K | -409K | -2.72M | -701K | -1.31M | -1.52M | -7K | 868K | -2.2M | 278K | -5.93M | 9.96M | -4.75M | 3.5M |
Operating Cash Flow | -772K | -592K | 26.65M | -1.68M | -1.92M | -7.38M | -6.37M | -7M | -9.38M | -7.13M | -6.14M | -8.19M | -7.77M | -15.13M | -9.58M | -21.45M | -15.31M |
Capital Expenditures | n/a | -2.25M | 2.25M | n/a | n/a | n/a | -1K | -135K | -61K | -116K | -14K | -57K | -29K | -359K | -370K | -1.88M | -717K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | 1.5M | 2K | n/a | 38K | 23K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | 1.54M | n/a | n/a | 38K | 23K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | -2.25M | 2.25M | n/a | n/a | 1.5M | 1K | -135K | -23K | -93K | -14K | -57K | -29K | -359K | -370K | -1.88M | -717K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | 125K | n/a | -11.86M | -6.25M | -6.25M | -2.08M | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -45K | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 24.95M | -24.95M | n/a | n/a | -18.11M | n/a | -125K | n/a | n/a | 21K | n/a | n/a | -186K | 24.93M | 19K | 1.02M |
Financial Cash Flow | n/a | n/a | -24.95M | n/a | n/a | n/a | n/a | -11.98M | -6.16M | 8.47M | -2.11M | n/a | n/a | -186K | 24.93M | 19K | 1.02M |
Net Cash Flow | -772K | -592K | -781K | -1.68M | -1.92M | -5.88M | -6.37M | -19.12M | -15.56M | 1.25M | -8.27M | -8.24M | -7.8M | -15.67M | 14.98M | -23.31M | -15.01M |
Free Cash Flow | -772K | -592K | 28.9M | -1.68M | -1.92M | -7.38M | -6.38M | -7.14M | -9.44M | -7.25M | -6.16M | -8.24M | -7.8M | -15.48M | -9.95M | -23.33M | -16.03M |